Mount Sinai Researchers Awarded $4.1 Million NIH Grant to Advance Understanding of Sleep Apnea Using Artificial Intelligence

Machine-learning method aims to predict consequences of serious sleep disorder impacting millions in the U.S.

Mount Sinai Researchers Develop Novel, Automated Measure of Sleep Studies to Determine Severity of Obstructive Sleep Apnea

New method can predict risks of cardiovascular disease, mortality in sleep apnea patients

Mount Sinai Experts Present Research at SLEEP 2023

Sleep medicine experts from the Mount Sinai Health System are presenting new research at SLEEP 2023, the 37th annual meeting of the Associated Professional Sleep Societies running until June 7 in Indianapolis.

New national indicator report details importance of prompt sleep apnea diagnosis and treatment

The Count on Sleep partnership, a collaboration between several professional and patient-focused organizations, has released a national indicator report for obstructive sleep apnea through a grant awarded to the American Academy of Sleep Medicine by the Centers for Disease Control and Prevention’s National Center for Chronic Disease Prevention and Health Promotion. The report provides an in-depth analysis of the symptoms, risk factors, prevalence, and burden of obstructive sleep apnea and serves as a resource for both the public and the health care communities on the importance of diagnosis and long-term treatment.

Study: Obstructive sleep apnea tied to weaker bones and teeth in adults

Obstructive sleep apnea may be linked to low bone mineral density in adults, according to University at Buffalo-led research. The findings are crucial for individuals with sleep apnea, as low bone mineral density is an indicator of osteoporosis – a condition in which bones become weak and brittle.

Study Finds Untreated Sleep Apnea May Increase Risk for Neurodegenerative Disease, PAP Therapies Crucial in Treating the Sleep Condition

Mount Sinai researchers have conducted one of the first studies to show the acute effect of obstructive sleep apnea on Alzheimer’s disease biomarkers, and the ability to even measure Alzheimer’s disease biomarkers from blood.

Protein Inhibitor May Lead to New Treatment for Low Oxygen Associated with Sleep Apnea

Article title: Lysine demethylase KDM6B regulates HIF-1α mediated systemic and cellular responses to intermittent hypoxia Authors: Jayasri Nanduri, Ning Wang, Benjamin L. Wang, Nanduri R. Prabhakar From the authors: “[The] current study demonstrates that pharmacological disruption of [Hypoxia-inducible factor]-1α activation…

Is it more than a snore? Recognizing sleep apnea warning signs

New research from the American Academy of Sleep Medicine (AASM), shows nearly 70% of Americans who sleep with a bed partner report that their partner snores while sleeping. Since snoring can be an indicator of sleep apnea, the AASM is asking Americans to consider, “Is it more than a snore?”

Study: Treatable Sleep Disorder Common in People with Thinking and Memory Problems

Obstructive sleep apnea is when breathing is repeatedly interrupted during sleep. Research has shown people with this sleep disorder have an increased risk of developing cognitive impairment and Alzheimer’s disease. Yet, it is treatable. A preliminary study released today, February 28, 2021, has found that obstructive sleep apnea is common in people with cognitive impairment. The study will be presented at the American Academy of Neurology’s 73rd Annual Meeting being held virtually April 17 to 22, 2021.